SynthesisMedicine2025
A comparative evaluation of alectinib for ALK-positive non-small-cell lung cancer: A systematic review.
Monica Kharat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
SynthesisMedicine2025
Monica Kharat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.